OXTENDA ODR

Welcome to the Brand page for “OXTENDA ODR”, which is offered here for Drug delivery systems, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;the wording oxtenda odr has no meaning in a foreign language.;research and development services for others in the pharmaceutical sciences, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;.

Its status is currently believed to be active. Its class is unavailable. “OXTENDA ODR” is believed to be currently owned by “Intellipharmaceutics Corp.”